Literature DB >> 18313025

Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study.

Denise Daley1, Susan Lewis, Petra Platzer, Melissa MacMillen, Joseph Willis, Robert C Elston, Sanford D Markowitz, Georgia L Wiesner.   

Abstract

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in Americans and is the second leading cause of cancer mortality. Only a minority ( approximately 5%) of familial CRC can be explained by known genetic variants. To identify susceptibility genes for familial colorectal neoplasia, the colon neoplasia sibling study conducted a comprehensive, genome-wide linkage scan of 194 kindreds. Clinical information (histopathology, size and number of polyps, and other primary cancers) was used in conjunction with age at onset and family history for classification of the families into five phenotypic subgroups (severe histopathology, oligopolyposis, young, colon/breast, and multiple cancer) prior to analysis. By expanding the traditional affected-sib-pair design to include unaffected and discordant sib pairs, analytical power and robustness to type I error were increased. Sib-pair linkage statistics and Haseman-Elston regression identified 19 linkage peaks, with interesting results for chromosomes 1p31.1, 15q14-q22, 17p13.3, and 21. At marker D1S1665 (1p31.1), there was strong evidence for linkage in the multiple-cancer subgroup (p = 0.00007). For chromosome 15q14-q22, a linkage peak was identified in the full-sample (p = 0.018), oligopolyposis (p = 0.003), and young (p = 0.0009) phenotypes. This region includes the HMPS/CRAC1 locus associated with hereditary mixed polyposis syndrome (HMPS) in families of Ashkenazi descent. We provide compelling evidence linking this region in families of European descent with oligopolyposis and/or young age at onset (<or=51) phenotypes. We found linkage to BRCA2 in the colon/breast phenotypic subgroup and identified a second locus in the region of D21S1437 segregating with, but distinct from, BRCA2. Linkage to 17p13.3 at marker D17S1308 in the breast/colon subgroup identified HIC1 as a candidate gene. We demonstrated that using clinical information, unaffected siblings, and family history can increase the analytical power of a linkage study.

Entities:  

Mesh:

Year:  2008        PMID: 18313025      PMCID: PMC2427227          DOI: 10.1016/j.ajhg.2008.01.007

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  56 in total

1.  Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology.

Authors:  D K Rex; D A Johnson; D A Lieberman; R W Burt; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

2.  Haseman and Elston revisited.

Authors:  R C Elston; S Buxbaum; K B Jacobs; J M Olson
Journal:  Genet Epidemiol       Date:  2000-07       Impact factor: 2.135

3.  Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers.

Authors:  C Dong; K Hemminki
Journal:  Int J Cancer       Date:  2001-06-15       Impact factor: 7.396

4.  Role of heredity in multiple primary cancer.

Authors:  H T Lynch; R E Harris; P M Lynch; H A Guirgis; J F Lynch; W A Bardawil
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

5.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

6.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.

Authors:  E Lander; L Kruglyak
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

7.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

8.  Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; H Gerdes; M J O'Brien; L S Gottlieb; S S Sternberg; J H Bond; J D Waye; M Schapiro; J F Panish
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

9.  Metachronous colon cancer in persons who have had a large adenomatous polyp.

Authors:  D P Otchy; D F Ransohoff; B G Wolff; A Weaver; D Ilstrup; H Carlson; D Rademacher
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

10.  Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.

Authors:  M Tavassoli; H Steingrimsdottir; E Pierce; X Jiang; M Alagoz; F Farzaneh; I G Campbell
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

View more
  20 in total

1.  Program update and novel use of the DESPAIR program to design a genome-wide linkage study using relative pairs.

Authors:  Heather M Ochs-Balcom; Xiuqing Guo; Takashi Yonebayashi; Georgia Wiesner; Robert C Elston
Journal:  Hum Hered       Date:  2009-10-02       Impact factor: 0.444

2.  Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer.

Authors:  Hironori Kumagai; Wellington Pham; Makoto Kataoka; Ken-Ichiro Hiwatari; James McBride; Kevin J Wilson; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Eric H Liu; John C Gore; Shinji Sakuma
Journal:  Int J Cancer       Date:  2012-10-30       Impact factor: 7.396

3.  Debate about TGFBR1 and the susceptibility to colorectal cancer.

Authors:  Laura Valle
Journal:  World J Gastrointest Oncol       Date:  2012-01-15

Review 4.  Hereditary and familial colon cancer.

Authors:  Kory W Jasperson; Thérèse M Tuohy; Deborah W Neklason; Randall W Burt
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

5.  Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.

Authors:  Ian W Saunders; Jason Ross; Finlay Macrae; Graeme P Young; Ignacio Blanco; Jesper Brohede; Glenn Brown; Diana Brookes; Trevor Lockett; Peter L Molloy; Victor Moreno; Gabriel Capella; Garry N Hannan
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

6.  Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X.

Authors:  E Sánchez-Tomé; B Rivera; J Perea; G Pita; D Rueda; F Mercadillo; A Canal; A Gonzalez-Neira; J Benitez; M Urioste
Journal:  J Gastroenterol       Date:  2014-11-09       Impact factor: 7.527

7.  Genetic heterogeneity in colorectal cancer associations between African and European americans.

Authors:  Sonia S Kupfer; Jeffrey R Anderson; Stanley Hooker; Andrew Skol; Rick A Kittles; Temitope O Keku; Robert S Sandler; Nathan A Ellis
Journal:  Gastroenterology       Date:  2010-07-24       Impact factor: 22.682

8.  Genes with relevance for early to late progression of colon carcinoma based on combined genomic and transcriptomic information from the same patients.

Authors:  Kristina K Lagerstedt; Erik Kristiansson; Christina Lönnroth; Marianne Andersson; Britt-Marie Iresjö; Annika Gustafsson; Elisabeth Hansson; Ulf Kressner; Svante Nordgren; Fredrik Enlund; Kent Lundholm
Journal:  Cancer Inform       Date:  2010-04-23

9.  Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.

Authors:  Marianne Berg; Trude H Agesen; Espen Thiis-Evensen; Marianne A Merok; Manuel R Teixeira; Morten H Vatn; Arild Nesbakken; Rolf I Skotheim; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2010-05-06       Impact factor: 27.401

10.  Principles of genetic predisposition to malignancies.

Authors:  Tadeusz Debniak; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.